NLS Companies

Flamel Technologies announced that it has entered into an agreement to divest its development and manufacturing facility located in Pessac, France, to RecipharmAB.  Under the agreement, Recipharm will pay Flamel EUR 10.6 million and make an investment of EUR 10.5 million in Flamel’s stock upon the closing of deal at a purchase price equal to […]

Meda, one of Recipharm’s customers, has today advised that it will transfer supply of its mainly Swedish penicillin products and manufacture offshore with other suppliers. The manufacturing contract with Recipharm Strängnäs will be terminated on Dec. 31, 2015. This business accounts for approximately 2% of Recipharm’s current sales. Recipharm currently employs 60 employees in Strängnäs and unfortunately the […]

Finnish medtech company Relaxbirth, which has developed a device to make the experience of childbirth better and quicker, is expanding to the U.S. and the Gulf.  A pilot project at the Summa Akron City Hospital in Ohio is yielding positive feedback while participation in the Global Access program of the UCLA Anderson Business School, where final […]

Glactone Pharma is a new project company within PULS, Sweden´s largest private incubator in life science.  Glactone Pharma develops a new drug against castration-resistant prostate cancer, a stage of the disease when the tumor is unresponsive to therapy with anti-hormonal drugs. This corresponds to approximately 40% of all prostate cancer patients and they lack effective […]